Concordant with the IWG-PM, ICC also excludes RUNX1 mutations from the SF3B1 entity supported by our data showing RUNX1 mutations as independent negative prognostic factors for OS and AML transformation. This evidence concerns the gene RUNX1 and acute myeloid leukemia.